期刊： EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2022; 130 (10)
Non-mesenchymal pancreatic cells are a potential source for cell replacement. Their transdifferentiation can be achieved by triggering epigenetic remo......
期刊： EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2022; 130 (9)
Mild autonomous cortisol secretion (mACS) is a state of cortisol excess usually associated with existence of adrenal incidentaloma. Because of the lac......
期刊： EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2022; 130 (12)
Introduction Advanced glycation end products (AGEs) are frequently increased in the skin of subjects with type 2 diabetes mellitus (T2DM). This study ......
期刊： EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2022; 130 (2)
The monocarboxylate transporter 8 (MCT8) is a specific thyroid hormone transporter and plays an essential role in fetal development. Inactivating muta......
期刊： EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2022; 130 (7)
Purpose To develop a simple and clinically useful assessment tool for osteoporosis in older women with type 2 diabetes mellitus (T2DM). Methods A tota......
期刊： EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2022; 130 (4)
Background Acromegaly is associated with an increased risk of fatal and non-fatal cardiovascular (CV) events. Controlling acromegaly decreases, but do......
期刊： EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2022; 130 (6)
Purpose To investigate the effectiveness of high-intensity focused ultrasound (HIFU) of solid and complex benign thyroid nodules. Methods Fifty-eight ......
期刊： EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2022; 130 (10)
In diabetes mellitus (DM), there is increased formation and accumulation of advanced glycation end products (AGEs), which represent a heterogeneous cl......
期刊： EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2022; 130 (11)
Background Not much is known about the effects of glycemic variability (GV) during the pre- and periconception period on pregnancy/perinatal complicat......
期刊： EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2022; 130 (6)
Aims of the study The minimum therapeutic goal regarding metabolic control for people with diabetes mellitus is the absence of symptoms of hyperglycem......
